Biosensors

Biosensors: - BIG's products are still the only stents with biodegradable polymer in the market. Abbott's biodegradable stent remains unproven. - Abbott’s biodegradable stent has obtained CE mark, but remains unproven as sample side is only 49 patients for 3 yr data and over 100 patients for one yr data. - Biofreedom - Mgt looking at CE mark approval this year or next. It will undergo 2,500 patient all comers trial in comparison with bare metal stents. - M&A opportunities - BIG is armed with US$300m cash and is seeking targets that have products near commercialisation, preferably dealing in high-value consumables that will help it to turn into a medical supplies company